These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10799653)

  • 1. Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs.
    Kreth K; Kovar K; Schwab M; Zanger UM
    Biochem Pharmacol; 2000 Jun; 59(12):1563-71. PubMed ID: 10799653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective differences in the cytochrome P450-dependent dealkylation and demethylenation of N-methyl-benzodioxolyl-butanamine (MBDB, Eden) enantiomers.
    Meyer MR; Peters FT; Maurer HH
    Biochem Pharmacol; 2009 Jun; 77(11):1725-34. PubMed ID: 19428327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers.
    Meyer MR; Peters FT; Maurer HH
    Toxicol Lett; 2009 Oct; 190(1):54-60. PubMed ID: 19576971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxyethylamphetamine and its single enantiomers.
    Meyer MR; Peters FT; Maurer HH
    Drug Metab Dispos; 2009 Jun; 37(6):1152-6. PubMed ID: 19299523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxy-methamphetamine and its enantiomers.
    Meyer MR; Peters FT; Maurer HH
    Drug Metab Dispos; 2008 Nov; 36(11):2345-54. PubMed ID: 18725511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of methylenedioxyphenyl compounds by rabbit liver preparations. Participation of different cytochrome P450 isozymes in the demethylenation reaction.
    Kumagai Y; Wickham KA; Schmitz DA; Cho AK
    Biochem Pharmacol; 1991 Aug; 42(5):1061-7. PubMed ID: 1678603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the cytochrome P450 isoenzymes involved in the in vitro N-dealkylation of haloperidol.
    Pan LP; Wijnant P; De Vriendt C; Rosseel MT; Belpaire FM
    Br J Clin Pharmacol; 1997 Dec; 44(6):557-64. PubMed ID: 9431831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicokinetics of lefetamine and derived diphenylethylamine designer drugs-Contribution of human cytochrome P450 isozymes to their main phase I metabolic steps.
    Wink CS; Meyer GM; Meyer MR; Maurer HH
    Toxicol Lett; 2015 Nov; 238(3):39-44. PubMed ID: 26276083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites.
    Botsch S; Gautier JC; Beaune P; Eichelbaum M; Kroemer HK
    Mol Pharmacol; 1993 Jan; 43(1):120-6. PubMed ID: 8423765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.
    Kumagai Y; Lin LY; Hiratsuka A; Narimatsu S; Suzuki T; Yamada H; Oguri K; Yoshimura H; Cho AK
    Mol Pharmacol; 1994 Feb; 45(2):359-65. PubMed ID: 7906857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4--implications for susceptibility to Parkinson's disease.
    Coleman T; Ellis SW; Martin IJ; Lennard MS; Tucker GT
    J Pharmacol Exp Ther; 1996 May; 277(2):685-90. PubMed ID: 8627546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomes.
    Turpeinen M; Hofmann U; Klein K; Mürdter T; Schwab M; Zanger UM
    Drug Metab Dispos; 2009 May; 37(5):1017-24. PubMed ID: 19204080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantioselectivity in the methylation of the catecholic phase I metabolites of methylenedioxy designer drugs and their capability to inhibit catechol-O-methyltransferase-catalyzed dopamine 3-methylation.
    Meyer MR; Maurer HH
    Chem Res Toxicol; 2009 Jun; 22(6):1205-11. PubMed ID: 19462939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azelastine N-demethylation by cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in human liver microsomes: evaluation of approach to predict the contribution of multiple CYPs.
    Nakajima M; Nakamura S; Tokudome S; Shimada N; Yamazaki H; Yokoi T
    Drug Metab Dispos; 1999 Dec; 27(12):1381-91. PubMed ID: 10570018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6).
    Tucker GT; Lennard MS; Ellis SW; Woods HF; Cho AK; Lin LY; Hiratsuka A; Schmitz DA; Chu TY
    Biochem Pharmacol; 1994 Mar; 47(7):1151-6. PubMed ID: 7909223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenproporex N-dealkylation to amphetamine--enantioselective in vitro studies in human liver microsomes as well as enantioselective in vivo studies in Wistar and Dark Agouti rats.
    Kraemer T; Pflugmann T; Bossmann M; Kneller NM; Peters FT; Paul LD; Springer D; Staack RF; Maurer HH
    Biochem Pharmacol; 2004 Sep; 68(5):947-57. PubMed ID: 15294457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor.
    Tang C; Shou M; Mei Q; Rushmore TH; Rodrigues AD
    J Pharmacol Exp Ther; 2000 May; 293(2):453-9. PubMed ID: 10773015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy').
    Maurer HH; Bickeboeller-Friedrich J; Kraemer T; Peters FT
    Toxicol Lett; 2000 Mar; 112-113():133-42. PubMed ID: 10720722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs.
    Brandes LJ; Queen GM; LaBella FS
    Cancer Chemother Pharmacol; 2000; 45(4):298-304. PubMed ID: 10755318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the human cytochrome P450 enzymes involved in the metabolism of dihydrocodeine.
    Kirkwood LC; Nation RL; Somogyi AA
    Br J Clin Pharmacol; 1997 Dec; 44(6):549-55. PubMed ID: 9431830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.